Inventor · disambiguated record
Yingzhong Li
Also filed as: LI YINGZHONG
10 granted patents·6 pending applications·143 citations·filing 2019–2025
87Inventor score
Files withMASSACHUSETTS INST TECHNOLOGY7LI YINGZHONG4SUNVAX MRNA THERAPEUTICS INC4SUNVAX MRNA THERAPEUTICS1
Top patents by PatentIndex Score
16 records- 0189USD893739SSex toyLI YINGZHONG·Filed 2019·Granted Aug 18, 2020·43 cites·1 claims
- 0289USD879992SSex toyLI YINGZHONG·Filed 2019·Granted Mar 31, 2020·43 cites·1 claims
- 0386USD879991SSex toyLI YINGZHONG·Filed 2019·Granted Mar 31, 2020·33 cites·1 claims
- 0483US12383589B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2023·Granted Aug 12, 2025·0 cites·19 claims
- 0581US11717548B2Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapyMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Aug 8, 2023·1 cites·22 claims
- 0681USD882108SSex toyLI YINGZHONG·Filed 2019·Granted Apr 21, 2020·23 cites·1 claims
- 0779US12416032B2Synthetic self-amplifying MRNA molecules with secretion antigen and immunomodulatorSUNVAX MRNA THERAPEUTICS INC·Filed 2024·Granted Sep 16, 2025·0 cites·27 claims
- 0874US12084703B2Synthetic self-amplifying mRNA molecules with secretion antigen and immunomodulatorSUNVAX MRNA THERAPEUTICS INC·Filed 2023·Granted Sep 10, 2024·0 cites·29 claims
- 0964US2024261223A1Modular lipid compounds and two- to three-component lipid nanoparticle compositionsSUNVAX MRNA THERAPEUTICS·Filed 2023·Application pending·0 cites
- 1061US12286646B2Methods for in vitro evolution of constructs derived from virusesMASSACHUSETTS INST TECHNOLOGY·Filed 2020·Granted Apr 29, 2025·0 cites·20 claims
- 1158US2023322689A1Ionizable lipid compounds and lipid nanoparticle compositionsSUNVAX MRNA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1257US2023313199A1Target for modulating body massMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 1351US2021324414A1Compositions and methods for sequestering virusesMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 1450US12139721B2Control of replication and transcription of self-replicating RNA in response to small moleculesMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Granted Nov 12, 2024·0 cites·20 claims
- 1550US2022016191A1Simultaneous delivery of cancer treatment programs to tumor and immune cellsMASSACHUSETTS INST TECHNOLOGY·Filed 2021·Application pending·0 cites
- 1646US2025281557A1Methods for cascade amplifications of therapeutic payloads (catp) & compositions for cancer immunotherapies and gene therapySUNVAX MRNA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yingzhong Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →